S&P 500   2,986.20 (-0.39%)
DOW   26,770.20 (-0.95%)
QQQ   191.69 (-0.96%)
AAPL   236.41 (+0.48%)
FB   185.85 (-2.38%)
MSFT   137.41 (-1.63%)
GOOGL   1,244.41 (-0.67%)
AMZN   1,757.51 (-1.68%)
NVDA   190.49 (-1.96%)
AMD   30.97 (-0.55%)
BAC   30.35 (+0.30%)
GILD   64.91 (-0.49%)
S&P 500   2,986.20 (-0.39%)
DOW   26,770.20 (-0.95%)
QQQ   191.69 (-0.96%)
AAPL   236.41 (+0.48%)
FB   185.85 (-2.38%)
MSFT   137.41 (-1.63%)
GOOGL   1,244.41 (-0.67%)
AMZN   1,757.51 (-1.68%)
NVDA   190.49 (-1.96%)
AMD   30.97 (-0.55%)
BAC   30.35 (+0.30%)
GILD   64.91 (-0.49%)
Log in

Rexahn Pharmaceuticals Price Target & Analyst Ratings (NASDAQ:REXN)

$1.98
+0.01 (+0.51 %)
(As of 10/18/2019 04:00 PM ET)
Today's Range
$1.90
Now: $1.98
$1.98
50-Day Range
$1.81
MA: $2.11
$2.37
52-Week Range
$1.80
Now: $1.98
$19.80
Volume12,635 shs
Average Volume90,367 shs
Market Capitalization$7.96 million
P/E RatioN/A
Dividend YieldN/A
Beta1.09

Analyst Ratings

Rexahn Pharmaceuticals (NASDAQ:REXN) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
3 Wall Street analysts have issued ratings and price targets for Rexahn Pharmaceuticals in the last 12 months. Their average twelve-month price target is $23.00, suggesting that the stock has a possible upside of 1,061.62%. The high price target for REXN is $23.00 and the low price target for REXN is $23.00. There are currently 2 hold ratings and 1 buy rating for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldBuyBuyBuy
Consensus Rating Score: 2.332.503.253.25
Ratings Breakdown: 0 Sell Rating(s)
2 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
1 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
1 Strong Buy Rating(s)
Consensus Price Target: $23.00$59.50$59.50$59.50
Price Target Upside: 1,061.62% upside2,188.46% upside844.44% upside844.44% upside

Rexahn Pharmaceuticals (NASDAQ:REXN) Consensus Price Target History

Rexahn Pharmaceuticals (NASDAQ:REXN) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
8/7/2019Ifs SecuritiesDowngradeStrong-Buy ➝ Market PerformHigh
8/7/2019HC WainwrightDowngradeBuy ➝ NeutralHigh
11/27/2018Brookline Capital ManagementReiterated RatingBuyN/A
10/2/2018B. RileySet Price TargetBuy$96.00N/A
(Data available from 10/18/2017 forward)
This page was last updated on 10/18/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel